Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aclarion, Inc. (ACON)

0.83   0.005 (0.61%) 03-24 15:59
Open: 0.8241 Pre. Close: 0.825
High: 0.83 Low: 0.8003
Volume: 12,923 Market Cap: 7(M)

Technical analysis

as of: 2023-03-24 4:23:45 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.1     One year: 1.29
Support: Support1: 0.76    Support2: 0.64
Resistance: Resistance1: 0.94    Resistance2: 1.1
Pivot: 0.73
Moving Average: MA(5): 0.81     MA(20): 0.72
MA(100): 0.72     MA(250): 0
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 58     %D(3): 55.3
RSI: RSI(14): 61.6
52-week: High: 4.05  Low: 0.37
Average Vol(K): 3-Month: 39 (K)  10-Days: 22 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ACON ] has closed below upper band by 13.4%. Bollinger Bands are 4.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.83 - 0.83 0.83 - 0.84
Low: 0.79 - 0.8 0.8 - 0.8
Close: 0.82 - 0.83 0.83 - 0.84

Company Description

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Headline News

Fri, 17 Mar 2023
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are ... - Benzinga

Tue, 07 Mar 2023
Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader ... - GlobeNewswire

Wed, 15 Feb 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace

Wed, 15 Feb 2023
Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium - Yahoo Finance

Mon, 06 Feb 2023
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks ... - Benzinga

Tue, 31 Jan 2023
Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon ... - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. 0 (M)
Shares Float 8 (M)
% Held by Insiders 4.98e+006 (%)
% Held by Institutions 33.9 (%)
Shares Short 61 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -5.9e+006
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -10
Return on Assets (ttm) 89.5
Return on Equity (ttm) -149.7
Qtrly Rev. Growth 60440
Gross Profit (p.s.) -0.01
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -1.7
Operating Cash Flow 0 (M)
Levered Free Cash Flow -5 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 60310
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.